BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16354006)

  • 41. Study of glimepiride-b-cyclodextrin complex.
    Moyano JR; Ventriglia T; Ginés JM; Muñoz F; Rabasco AM
    Boll Chim Farm; 2003 Nov; 142(9):390-5. PubMed ID: 14971307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of inclusion complexation between fenoxaprop-p-ethyl and cyclodextrin.
    Zhang A; Liu W; Wang L; Wen Y
    J Agric Food Chem; 2005 Sep; 53(18):7193-7. PubMed ID: 16131129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes.
    Cao F; Guo J; Ping Q
    Drug Dev Ind Pharm; 2005 Sep; 31(8):747-56. PubMed ID: 16221609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets.
    Dahiya S; Pathak K
    Pharmazie; 2007 Apr; 62(4):278-83. PubMed ID: 17484283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
    Zhou Q; Wei X; Dou W; Chou G; Wang Z
    Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
    Garnero C; Aiassa V; Longhi M
    J Pharm Biomed Anal; 2012 Apr; 63():74-9. PubMed ID: 22361661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of preparation processes and structural insight into the supermolecular system: Bisacodyl and β-cyclodextrin inclusion complex.
    Li S; Zhai Y; Yan J; Wang L; Xu K; Li H
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():224-32. PubMed ID: 26478306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and
    Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of inclusion behaviour of gefitinib with epichlorohydrin-β-cyclodextrin polymer: preparation of binary complex, stoichiometric determination and characterization.
    Gidwani B; Vyas A; Deep Kaur C
    J Pharm Biomed Anal; 2018 Oct; 160():31-37. PubMed ID: 30059812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
    Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
    Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
    Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions of griseofulvin with cyclodextrins in solid binary systems.
    Veiga MD; Díaz PJ; Ahsan F
    J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation, characterization and dissolution enhancement of mefloquine hydrochloride-betaCD inclusion complex.
    Patil SS; Patil AL
    Pharmazie; 2011 Jun; 66(6):416-20. PubMed ID: 21699079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T; Rajendrakumar K
    J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
    Mennini N; Bragagni M; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C; Zoppi A; Genovese D; Longhi M
    Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.